Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 0.00 | € 2.75B | € 3.31B | € 3.09B | € 2.75B |
Total Assets | - | € 43.41B | € 44.40B | € 38.15B | € 36.70B |
Total Debt | € 0.00 | € 11.53B | € 11.66B | € 7.76B | € 6.78B |
Net Debt | € 0.00 | € 8.78B | € 8.35B | € 4.67B | € 4.03B |
Total Liabilities | - | € 15.46B | € 17.32B | € 11.54B | € 10.87B |
Stockholders Equity | € 0.00 | € 25.03B | € 24.17B | € 23.68B | € 22.98B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |